Thyrotoxic periodic paralysis and anesthesia report of a case and literature review

Journal of Clinical Anesthesia

Volumn 18, Issue 4, 2006, Pages 286-292

  Diedrich, Daniel A ^a   Wedel, Denise J ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Anesthesia; Hyperthyroidism; Hypokalemia; Paralysis; Thyrotoxic periodic paralysis; TPP

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; FENTANYL; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; LIDOCAINE; MIDAZOLAM; NEOSTIGMINE; NITROUS OXIDE; OXYMORPHONE; POTASSIUM; PROPOFOL; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FOLLOW UP; GENERAL ANESTHESIA; GRAVES DISEASE; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REGIONAL ANESTHESIA; THYROIDECTOMY; THYROTOXIC PERIODIC PARALYSIS; THYROTOXICOSIS;

ADULT; ANESTHESIA, GENERAL; FEMALE; GRAVES DISEASE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MIDDLE AGED; THYROTOXICOSIS;

EID: 33745213141     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2005.08.016     Document Type: Article

References (69)

1. Robson N.J. Emergency surgery complicated by thyrotoxicosis and thyrotoxic periodic paralysis. Anaesthesia 40 (1985) 27-31
2. Ober K.P. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore) 71 (1992) 109-120
3. Manoukian M.A., Foote J.A., and Crapo L.M. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159 (1999) 601-606
4. McFadzean A.J., and Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ 1 (1967) 451-455
5. Edelman J., and Stewart-Wynne E.G. Respiratory and bulbar paralysis with relapsing hyperthyroidism. BMJ (Clin Res Ed) 283 (1981) 275-276
6. Crane M. Periodic paralysis associated with hyperthyroidism. CA Med J 92 (1960) 285-288
7. Liu Y.C., Tsai W.S., Chau T., and Lin S.H. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci 327 (2004) 264-267
8. Birkhahn R.H., Gaeta T.J., and Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 18 (2000) 199-202
9. Norris K.C., Levine B., and Ganesan K. Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis 28 (1996) 270-273
10. Ferreiro J.E., Arguelles D.J., and Rams Jr. H. Thyrotoxic periodic paralysis. Am J Med 80 (1986) 146-150
11. Magsino Jr. C.H., and Ryan Jr. A.J. Thyrotoxic periodic paralysis. South Med J 93 (2000) 996-1003
12. Kelley D.E., Gharib H., Kennedy F.P., Duda Jr. R.J., and McManis P.G. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 149 (1989) 2597-2600
13. Kiso Y., Yoshida K., Kaise K., et al. A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis. Jpn J Med 29 (1990) 399-404
14. Chen Y.C., Fang J.T., Chang C.T., and Chou H.H. Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail 23 (2001) 139-142
15. Tinker T.D., and Vannatta J.B. Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature (1). J Okla State Med Assoc 80 (1987) 11-15
16. Shizume K., Shishiba Y., Sakuma M., Yamauchi H., Nakao K., and Okinaka S. Studies on electrolytes metabolism in idiopathic and thyrotoxic periodic paralysis. II. Total exchangeable sodium and potassium. Metabolism 15 (1966) 145-152
17. Engel A. Thyroid function and periodic paralysis. Am J Med 30 (1961) 327-333
18. Shizume K., Shishiba Y., Sakuma M., Yamauchi H., Nakao K., and Okinaka S. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism 15 (1966) 138-144
19. Nora N.A., and Berns A.S. Hypokalaemic, hypophosphatemic thyrotoxic periodic paralysis. Am J Kidney Dis 13 (1989) 247-249
20. Guthrie Jr. G.P., Curtis J.J., and Beilman K.M. Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med 138 (1978) 1284-1285
21. Chia B.L., Lee K.H., and Cheah J.S. Sino-atrial Wenckebach conduction in thyrotoxic periodic paralysis: a case report. Int J Cardiol 47 (1995) 285-289
22. Huszar R.J. Basic dysrhythmias: interpretation & management (2002), Mosby, St. Louis 544
23. Hsu Y.J., Lin Y.F., Chau T., Liou J.T., Kuo S.W., and Lin S.H. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci 326 (2003) 128-132
24. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 142 (1982) 1362-1364
25. Tassone H., Moulin A., and Henderson S.O. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 26 (2004) 157-161
26. Okinaka S., Shizume K., Iino S., et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 17 (1957) 1454-1459
27. Satoyoshi E., Murakami K., Kowa H., Kinoshita M., and Nishiyama Y. Periodic paralysis in hyperthyroidism. Neurology 13 (1963) 746-752
28. Lin Y.F., Wu C.C., Pei D., Chu S.J., and Lin S.H. Diagnosing thyrotoxic periodic paralysis in the ED. Am J Emerg Med 21 (2003) 339-342
29. Kjeldsen K., Norgaard A., Gotzsche C.O., Thomassen A., and Clausen T. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet 2 (1984) 8-10
30. Arnott R.D., White R., and Jerums G. Effect of thyroid status on ouabain binding to the human lymphocyte. J Clin Endocrinol Metab 54 (1982) 1150-1156
31. Khan F.A., and Baron D.N. Ion flux and Na+,K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci (Lond) 72 (1987) 171-179
32. Chan A., Shinde R., Chow C.C., Cockram C.S., and Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303 (1991) 1096-1099
33. Asano Y., Liberman U.A., and Edelman I.S. Thyroid thermogenesis. Relationships between Na+-dependent respiration and Na+ + K+-adenosine triphosphatase activity in rat skeletal muscle. J Clin Invest 57 (1976) 368-379
34. Oh V.M., Taylor E.A., Yeo S.H., and Lee K.O. Cation transport across lymphocyte plasma membranes in euthyroid and thyrotoxic men with and without hypokalaemic periodic paralysis. Clin Sci (Lond) 78 (1990) 199-206
35. Conway M.J., Seibel J.A., and Eaton P. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med 81 (1974) 332-336
36. Lin S.H., Lin Y.F., and Halperin M.L. Hypokalaemia and paralysis. QJM 94 (2001) 133-139
37. Mehta S.R., Verma A., Malhotra H., and Mehta S. Normokalaemic periodic paralysis as the presenting manifestation of hyperthyroidism. J Assoc Physicians India 38 (1990) 296-297
38. Adachihara K., and Takagi Y. Case of thyrotoxic paralysis associated with hyperkalemic and hypokalemic paralytic attacks. Rinsho Shinkeigaku 14 (1974) 369-375
39. Chan A., Shinde R., Chow C.C., Cockram C.S., and Swaminathan R. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol (Oxf) 41 (1994) 213-216
40. Levey G.S., and Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88 (1990) 642-646
41. Brown M.J., Brown D.C., and Murphy M.B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309 (1983) 1414-1419
42. Braden G.L., von Oeyen P.T., Germain M.J., Watson D.J., and Haag B.L. Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences. Kidney Int 51 (1997) 1867-1875
43. Engel A.G. Neuromuscular manifestations of Graves' disease. Mayo Clin Proc 47 (1972) 919-925
44. Shayne P., and Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med 24 (1994) 736-740
45. Body J.J., Cryer P.E., Offord K.P., and Heath III H. Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin. J Clin Invest 71 (1983) 572-578
46. Au K.S., and Yeung R.T. Thyrotoxic periodic paralysis. Periodic variation in the muscle calcium pump activity. Arch Neurol 26 (1972) 543-546
47. Fontaine B., Vale-Santos J., Jurkat-Rott K., et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet 6 (1994) 267-272
48. Morrill J.A., Brown Jr. R.H., and Cannon S.C. Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. J Neurosci 18 (1998) 10320-10334
49. Chen L., Lang D., Ran X.W., Joncourt F., Gallati S., and Burgunder J.M. Clinical and molecular analysis of Chinese patients with thyrotoxic periodic paralysis. Eur Neurol 49 (2003) 227-230
50. Dias da Silva M.R., Cerutti J.M., Tengan C.H., et al. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin Endocrinol (Oxf) 56 (2002) 367-375
51. Bulow Pedersen I., Knudsen N., Jorgensen T., Perrild H., Ovesen L., and Laurberg P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 87 (2002) 4462-4469
52. Kufs W.M., McBiles M., and Jurney T. Familial thyrotoxic periodic paralysis. West J Med 150 (1989) 461-463
53. Yeo P.P., Chan S.H., Lui K.F., Wee G.B., Lim P., and Cheah J.S. HLA and thyrotoxic periodic paralysis. BMJ 2 (1978) 930
54. Hawkins B.R., Ma J.T., Lam K.S., Wang C.C., and Yeung R.T. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin Endocrinol (Oxf) 23 (1985) 245-252
55. Hawkins B.R., Ma J.T., Lam K.S., Wang C.C., and Yeung R.T. Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong. Acta Endocrinol (Copenh) 110 (1985) 66-69
56. Tamai H., Tanaka K., Komaki G., et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab 64 (1987) 1075-1078
57. Lazarus J.H. Hyperthyroidism. Lancet 349 (1997) 339-343
58. Dias Da Silva M.R., Cerutti J.M., Arnaldi L.A., and Maciel R.M. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87 (2002) 4881-4884
59. Abbott G.W., Butler M.H., Bendahhou S., Dalakas M.C., Ptacek L.J., and Goldstein S.A. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104 (2001) 217-231
60. Tang N.L., Chow C.C., Ko G.T., et al. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients. Clin Endocrinol 61 (2004) 109-112
61. Kung A.W., Lau K.S., Fong G.C., and Chan V. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89 (2004) 1340-1345
62. Gandara D.R., and Fariss B.L. Persistence of periodic paralysis following treatment of thyrotoxicosis: case report. Mil Med 144 (1979) 337-338
63. Yeo P.P., and O'Neill W.C. Thyrotoxicosis and periodic paralysis. Med Grand Rounds 3 (1984) 10-25
64. Lin S.H., and Lin Y.F. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 37 (2001) 620-623
65. Shulkin D., Olson B.R., and Levey G.S. Thyrotoxic periodic paralysis in a Latin-American taking acetazolamide. Am J Med Sci 297 (1989) 337-338
66. Cooper D.S. Hyperthyroidism. Lancet 362 (2003) 459-468
67. Thorne A.C., and Bedford R.F. Esmolol for perioperative management of thyrotoxic goiter. Anesthesiology 71 (1989) 291-294
68. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
69. Naguib M., and Lien C.A. Pharmacology of muscle relaxants and their antagonists. In: Miller R.D. (Ed). Anesthesia. 6th ed (2005), Elsevier-Livingstone, Philadelphia 481-572